Prof. Enrico Lopriore joins JCTR clinical editorial board

August 30, 2022

Enrico Lopriore is a professor of neonatology and fetal medicine and head of the Neonatal Intensive Care Unit at the Leiden University Medical Center (LUMC), The Netherlands. 

The research from Enrico Lopriore focuses mainly on the origin, management and outcome in various fetal disorders, including complicated monochorionic twins (with TTS, TAPS or sIUGR) and fetal hematologic diseases (anemia or thrombocytopenia). The ultimate goal of his research is to improve perinatal survival and in particular the long-term outcome in these vulnerable babies.

Enrico Lopriore absolved Medical School and his doctoral research at Leiden University. He was appointed Professor in Neonatology of the Leiden University Medical Center in July 2016. Enrico's publication record can be found .

Dr. Ibrahim Ince joins JCTR clinical editorial board

August 9, 2022

Ibrahim Ince studied Bio-pharmaceutical sciences in Leiden, the Netherlands, and obtained his PhD in the field of Pharmacology and Pharmacometrics at the Erasmus Medical Center - Sophia Children's Hospital in Rotterdam, the Netherlands. Since 2014 he is working as expert in systems pharmacology and medicine, and as pharmacometrics leader at the pharmacometrics department at Bayer AG, Germany. Ibrahim is involved in physiology-based pharmacokinetics (PBPK) in silico modeling and simulation in several clinical drug development projects within Bayer AG in the field of cardiovascular diseases, infectious diseases and to a lesser extend oncology. He is particularly specialized in model based extrapolation to special populations such as pediatrics, renal- and hepatic impaired patient populations. Ibrahim's publication record can be found .

Dr. Frank Schaap promoted to associate editor

July 29, 2022

Frank Schaap studied biochemistry and molecular biology, and obtained his PhD in the field of cardiac physiology. Working as a postdoc at the department of Experimental Hepatology (AMC, Amsterdam) and the Tytgat Institute for Liver and Intestinal Research (Amsterdam), he became fascinated by the biology and endocrine actions of bile salts. He is appointed at the Department of Surgery at the university hospitals in Maastricht, The Netherlands, and Aachen, Germany. His team studies the role of the gut-liver bile salt signaling axis in intestinal and liver health and disease, and his research has a translational character, employing the (surgical) patient with perturbed enterohepatic circulation as a 'model'. Frank's publication record can be found . 

Special issue on regenerative medicine in head and neck

July 27, 2022

JCTR is organizing a special issue with Guest Editor, Prof. Petros D. Karkos, on regenerative medicine in head and neck: clinical and basic science perspectives. The submission deadline is October 31, 2023. 

Prof. Karkos is an associate professor in otolaryngology at Aristotle University of Thessaloniki in Greece. Find more information about this special issue .

JCTR welcomes Prof. Joshua A. Jackman

July 26, 2022

Prof. Joshua A. Jackman joins  of JCTR. Prof. Joshua A. Jackman is an assistant professor in the School of chemical engineering and biomedical institute for convergence at Sungkyunkwan University (SKKU) in South Korea. He is also the director of the translational nanobioscience research center at SKKU.

JCTR will adopt article processing charges per August 1^st, 2022 (9 am CET)

July 14, 2022

Since its inauguration in 2015, JCTR operations have been funded by the publisher and editorial team throughout its seven-year existence. During this period, we have expanded the journal's support network and built value for contributors. The journal is poised to reach the final major milestone, which is indexation by the Web of Science database and, in due course, receiving an impact factor. To cover the reorganization at the publisher and costs related to the publishing process, JCTR will adopt an article processing charge (APC) of USD 1000 for the publication of an accepted article submitted on or after August 1, 2022 (starting 9 am CET). Upon acceptance of a manuscript, authors will be asked to pay the APC, which will release their manuscript for publication.

APC discounts and waivers

We encourage authors to publish their papers with JCTR and do not wish the APC cost to become a barrier, especially to authors based in the low-income or lower middle-income countries/regions as defined by the World Bank. Authors from these countries/regions are encouraged to use the discount rate/waiver offered by the publisher.

JCTR is proud to annouce the expansion of the editorial team

The following members have joined the editorial team of JCTR:

Prof. Andrew G. Lee.
Andrew G. Lee, MD is the Herb and Jean Lyman Centennial Chair in Ophthalmology and is the Founding Chairman of the Blanton Eye Institute, Department of Ophthalmology at Houston Methodist Hospital in Houston, Texas and is Professor of Ophthalmology, Neurology, and Neurosurgery at Weill Cornell Medicine. He is adjunct professor of Ophthalmology at Baylor College of Medicine; Texas A and M College of Medicine; University of Iowa and the University of Buffalo; and Clinical Professor at the University of Texas Medical Branch in Galveston, Texas and the UT MD Anderson Cancer Center.

Prof. Marc Jeschke
Marc Jeschke , MD, PhD, FACS, FRCSC has been caring for burn patients and conducting research in the field of burns for over 20 years. He is a global leader in burn care, research, and education; according to Expertscape, he is the second highest-ranked expert in burns in the world. Dr. Jeschke was Director of the Ross Tilley Burn Centre at Sunnybrook Health Sciences Centre from 2010 to 2021. He is a Surgeon Scientist and a Professor in the Departments of Surgery and Immunology at the University of Toronto. He also is the Director of the Translational Research Committee for the Department of Surgery at the University of Toronto. As of July 4, 2022, Dr. Jeschke will become the VP of Research and Head of the Burn Program, at Hamilton Health Sciences Centre and McMaster University.

Prof. Khalid Siddiqui
Khalid Siddiqui, PhD is associate professor and researcher at the Strategic Center for Diabetes Research of College of Medicine, King Saud University Riyadh, Saudi Arabia.

Prof. Shuqun Cheng
Shuqun Cheng Md, PhD is a hepatic surgen at Eastern Hepatobiliary Surgery Hospital in Shanghai, China.He was honoured by Chang Jiang Scholar in 2012 and Distinguished Young Scientist for The China National Funds in 2011. As a hepatic surgeon, he did almost 400 operations for liver cancer resection every year. His main contribution focused on the proposing a new Portal Vein Tumor Thrombosis (PVTT) classification and early antiviral therapy for guiding the surgical treatment for Hepatocellular carcinoma (HCC) and established PVTT cell lines for HCC metastasis study.

Dr. Sumanta Saha
Sumanta Saha is a doctor and epidemiologist from India. He is presently a teaching faculty at the Dept. of Community Medicine, R. G. Kar Medical College, Kolkata, India. His research interests include both communicable and non-communicable diseases. He has publications on various health topics, including pediatric infectious diseases, antenatal and perinatal issues, diabetes, and COVID-19.

Dr. Tony Kleijn
Tony Kleijn is a pathology resident at the University Medical Center Groningen (UMCG). He is on the board of the National Pathology Assistants Association (LPAV) to represent the interests of dutch AIOS, and is also involved in various training and (international) research projects of the UMCG.

Prof. Vikrant Rai
Vikrant Rai is an Assistant Professor in the Department of Translational Research at the Western University of Health Sciences, Pomona, CA. His research interests are investigating inflammatory molecular pathologies underlying various chronic inflammatory diseases and delineating immunomodulation and immunotherapeutic strategies.

JCTR's statement on "paid citations" reported by Retraction Watch

At the end of September, the editorial team of JCTR in Singapore received inquiries from authors regarding cash remuneration for researchers who cite articles published in JCTR in their own papers. This practice was addressed in a recent publication on the Retraction Watch website under the title “Publisher offers cash for citations". This incident was addressed to editor-in-chief and managing editor of JCTR on October 8th.

The editorial board of JCTR attests that none of the in-house editors and journal staff were cognizant of these practices up until October 8th. The editors and journal staff were never involved in any fashion in gaming the metrics for any purpose, and specifically for purposes of citation gauging. We strongly condemn such unethical practices and will never engage in such acts. Accordingly, JCTR will not entertain cash requests from individuals who claim to have cited our articles, nor shall we provide any payment for citations to JCTR articles.

Key editorial staff members convened on October 10th to properly resolve this issue. We have learned that JCTR was listed as "related journal" on Innoscience website for 10 months until mid-August. These unauthorized campaign operations by Innoscience with respect to JCTR were ceased immediately. JCTR did not and will never provide financial support or any means of support to such unauthorized campaign acts.

We would also like to clarify that our editorial decisions on submissions, selection of editorial board members, and the integrity of published articles are not affected by the commercial entities that were formerly associated with the campaign.

Michal Heger, editor-in-chief

Journal of Clinical and Translational Research

October 10, 2021